From bench to bedside – A mission for a healthy life

From bench to bedside – A mission for a healthy life

The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.

Scientific Seminars

Research Topics at DRFZ

Research Groups

cf

Mass Cytometry

Each cell is unique

Mass cytometry permits deep cellular phenotyping in clinical immunology and basic research, with more than 50 parameters that can be measured simultaneously in a single assay. This is achieved by combining principles of flow cytometry and inductively coupled plasma mass spectrometry (ICP-MS), a technology that has been developed for trace metal analysis. read more

Leibniz ScienceCampus Berlin Chronic Inflammation

Investigating the causes of chronic inflammation

Doctors and researchers at the Charité – Universitätsmedizin Berlin and the Leibniz-Institute Deutsches Rheuma-Forschungszentrum Berlin have been working together since 2016 to investigate the wide-ranging causes of chronic inflammation and to find new ways to treat these diseases. The Leibniz Association has established the Leibniz ScienceCampus Chronic Inflammation and is supporting it with 1.2 million euros for 4 years.

30 Jahre Deutsches Rheuma-Forschungszentrum Berlin Das Deutsche Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, wurde vor 30 Jahren, 1988, durch das Land Berlin gegründet, dem es für die vielen Jahre der großzügigen Unterstützung und konstruktiven Begleitung zu großem Dank verpflichtet ist.